Zydus Q3 net down 5% to Rs 500 cr as sales dip in US and domestic markets

Revenue from operations nearly flat at Rs 3,655 crore in reporting quarter

A dip in both the US and India sales has led to Cadila Healthcare Limited (Zydus Cadila) posting a five per cent fall in its consolidated net profit on a year-on-year (YoY) basis for the quarter ended December 31, 2021. As compared to Rs 527.2 crore in Q3 of previous financial year 2020-21, the net profit stood at Rs 500.4 crore in the said quarter of current fiscal 2021-22.

Revenue from operations was up by a marginal one per cent at Rs 3,655 crore in Q3 of FY22 as against Rs 3,591.5 crore in Q3 of FY21.

Zydus' US sales